Thrombophilia Assessment Under DOAC: Effectiveness of Activated Charcoal
Condition(s):ThrombophiliaLast Updated:December 15, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):ThrombophiliaLast Updated:December 15, 2023Recruiting
Condition(s):Anticoagulant TherapyLast Updated:April 21, 2022Completed
Condition(s):Venous Thromboembolism; Atrial FibrillationLast Updated:October 6, 2021Completed
Condition(s):Cancer; Venous Thromboembolism; Deep Vein Thrombosis (DVT); Pulmonary Embolism (PE); Blood ClotLast Updated:October 3, 2023Completed
Condition(s):Lymphoma; Acute Lymphoblastic LeukemiaLast Updated:March 8, 2022Completed
Condition(s):Ventricular Tachycardia; Premature Ventricular Contraction; StrokeLast Updated:August 22, 2022Completed
Condition(s):Anticoagulants; Platelet Aggregation Inhibitors; Stents; Atrial FibrillationLast Updated:January 15, 2013Completed
Condition(s):Acute Myocardial InfarctionLast Updated:December 13, 2021Completed
Condition(s):AnticoagulantsLast Updated:September 22, 2021Completed
Condition(s):Atrial FibrillationLast Updated:March 4, 2019Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.